INSIGHTS ON DRUG DEVELOPMENT
-
![Thermo Model to Molecule Webinar]( "From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development")
From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug DevelopmentSee how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.
-
![GettyImages-1807380819-scientist-laboratory-equipment-research]( "Temperature Dependence On Reversed-Phase Separations")
Temperature Dependence On Reversed-Phase SeparationsColumn temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.
-
![iStock-459537393-pill-softgel-capsule]( "Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based Formulations")
Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based FormulationsDevelop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials.
-
![global SARS COVID pandemic vaccine-GettyImages-1299440500]( "Keeping The Momentum In Pandemic Preparedness")
Keeping The Momentum In Pandemic PreparednessLearn about the partnership between the Prairie HUB and Cytiva to create RNA vaccines to target potential pandemic viruses with the aim of redefining global pandemic preparedness.
-
Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine6/25/2026
Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.
-
Data-Driven Strategies To De-Risk OSD Development6/17/2026
Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.
-
Accelerating Development With Rapid Delivery Of Toxicological Study Material3/19/2025
Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.
-
Sustainability In On-Body Delivery System Platforms7/2/2026
Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.
-
Your Guide To Precise And Robust Separation Methods11/12/2025
Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
DRUG DEVELOPMENT SOLUTIONS
-
![CELLULAR FOCUS™]( "Customizable Imaging Workstations")
Examine a customizable imaging workstation designed for complex research needs, combining precision engineering, flexible components, and intuitive software to support advanced applications.
-
![iStock-186109117-equipment-worker-lab]( "Continuous Flow")
Our team of experts can assess processes for suitable application of continuous flow culminating in the custom development of processes incorporating proof-of-concept to cGMP manufacturing and commercialization.
-
![Elizabeth Hata Pharmaceutical 10 Station Tablet Press]( "Used Elizabeth Hata Pharmaceutical 10 Station Tablet Press")
Used Elizabeth Hata R&D tablet press, model EP200, B/D tooled with 10 station turret, 5 stations each B and D, 16 mm B, 22 mm D max tablet diameter, 17 mm B, 18 mm D max depth of fill, rated up to 6000 tablets/hour, with feed hoppers and feed frames, Machine #81, built 2011.
-
![Observe Cell viability With SpectraMax MiniMax 300 Imaging Cytometer]( "Observe Cell Viability With SpectraMax MiniMax 300 Imaging Cytometer")
Observe the viability of your cells with the field-upgradeable cellular imaging option for the SpectraMax i3/i3x Multi-mode Detection Platform.
-
![Contract Research Services]( "Contract Research Services For Drug Discovery And Development")
Understand and predict human response earlier in the drug development process, and harness the advantages of Organ-on-a-Chip technology without needing to invest in capital equipment or train personnel.
